Lumida
/CLB
⌘K
Core Laboratories Inc

Core Laboratories Inc

CLB
$12.50USD-0.24%-0.03 today

MARKET CAP

573.6M

P/E (TTM)

20.5x

FWD P/E

DAY RANGE

$12 – $13

52W RANGE

$10
$20

AI Summary

Stalk
Buy NowMedium

CLB is in a Stage 4 decline but is mean-reversion eligible, warranting a tactical bullish stance. The post-capitulation pattern and extreme oversold context signal supply exhaustion and potential stabilization around the washout low, and short-term price action shows a strong recovery bar with volume confirming initial acceptance, supporting immediate participation on this rebound.

  • Q4 2025 revenue reached $138.3M, up 3% QoQ and 7% YoY.
  • Repurchased $2.7M in stock in Q2 2026, seventh consecutive buyback.
  • Q2 2026 net income fell to $5.1M, down 72% QoQ.
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income